Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: SEGUIMENTOS, OBESIDADE (INCIDÊNCIA), METABOLISMO (FISIOPATOLOGIA), HIDROXILASE, MULHERES, RESUMOS (EVENTOS)
ABNT
MOREIRA, R P P et al. Long-Term dexamethasone treatment is not associated with obesity and or metabolic syndrome in adult patients with classical forms of 21-hydroxylase deficiency. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 15 maio 2024. , 2010APA
Moreira, R. P. P., Gomes, L. G., Madureira, G., Mendonça, B. B. de, & Bachega, T. A. S. S. (2010). Long-Term dexamethasone treatment is not associated with obesity and or metabolic syndrome in adult patients with classical forms of 21-hydroxylase deficiency. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.NLM
Moreira RPP, Gomes LG, Madureira G, Mendonça BB de, Bachega TASS. Long-Term dexamethasone treatment is not associated with obesity and or metabolic syndrome in adult patients with classical forms of 21-hydroxylase deficiency. Clinics. 2010 ; 65 S70.[citado 2024 maio 15 ]Vancouver
Moreira RPP, Gomes LG, Madureira G, Mendonça BB de, Bachega TASS. Long-Term dexamethasone treatment is not associated with obesity and or metabolic syndrome in adult patients with classical forms of 21-hydroxylase deficiency. Clinics. 2010 ; 65 S70.[citado 2024 maio 15 ]